financetom
Business
financetom
/
Business
/
Rocket Lab Surging Wednesday After Better-Than-Expected Q3 Results, Above-Consensus Q4 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rocket Lab Surging Wednesday After Better-Than-Expected Q3 Results, Above-Consensus Q4 Outlook
Nov 13, 2024 8:46 AM

11:28 AM EST, 11/13/2024 (MT Newswires) -- Rocket Lab USA ( RKLB ) rallied Wednesday, climbing nearly 50%, after overnight reporting Q3 financial results topping Wall Street expectations and forecasting revenue for the current quarter also exceeding the analyst consensus.

Rocket Lab, a space services company, recorded a net loss of $0.10 per diluted share on $104.8 million in revenue during the three months ended Sept. 30. That compares with the consensus call of analysts polled by Capital IQ expecting a Q3 loss of $0.11 per share on $102.4 million in revenue.

The company also is projecting Q4 revenue in a range of $125 million and $135 million while analysts, on average, are looking for $122.2 million in revenue for the quarter.

Also Tuesday, Rocket Lab said it signed a multi-launch agreement with a confidential commercial satellite constellation operator for its new Neutron rocket. The company will launch two missions on the Neutron in mid-2026. Financial terms were not disclosed.

Price: 21.87, Change: +7.21, Percent Change: +49.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Columbia Sportswear Q4 Earnings, Sales Increase; Sets Q1 Guidance; Shares Slump After Hours
Columbia Sportswear Q4 Earnings, Sales Increase; Sets Q1 Guidance; Shares Slump After Hours
Feb 4, 2025
05:35 PM EST, 02/04/2025 (MT Newswires) -- Columbia Sportswear ( COLM ) reported Q4 earnings late Tuesday of $1.80 per diluted share, up from $1.55 a year earlier. Analysts polled by FactSet expected $1.89. Net sales for the quarter that ended Dec. 31 was $1.10 billion, up from $1.06 billion a year earlier. Analysts surveyed by FactSet expected $1.08 billion....
Simulations Plus Insider Sold Shares Worth $678,243, According to a Recent SEC Filing
Simulations Plus Insider Sold Shares Worth $678,243, According to a Recent SEC Filing
Feb 4, 2025
05:37 PM EST, 02/04/2025 (MT Newswires) -- Walter S Woltosz, 10% Owner, Director, on February 03, 2025, sold 20,000 shares in Simulations Plus ( SLP ) for $678,243. Following the Form 4 filing with the SEC, Woltosz has control over a total of 3,402,584 common shares of the company, with 3,402,584 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1023459/000102345925000014/xslF345X05/wk-form4_1738708430.xml ...
Hanover Insurance Q4 Operating Income, Revenue Rise
Hanover Insurance Q4 Operating Income, Revenue Rise
Feb 4, 2025
05:37 PM EST, 02/04/2025 (MT Newswires) -- Hanover Insurance Group ( THG ) reported Q4 operating income late Tuesday of $5.32 per diluted share, up from $3.13 a year earlier. Analysts polled by FactSet expected $3.36. Revenue for the quarter ended Dec. 31 rose to $1.58 billion from $1.53 billion a year earlier. Two analysts surveyed by FactSet expected $1.61...
Qiagen Gets Patent Reaffirmation From German Court
Qiagen Gets Patent Reaffirmation From German Court
Feb 4, 2025
05:40 PM EST, 02/04/2025 (MT Newswires) -- Qiagen ( QGEN ) said Tuesday the German Federal Patent Court reaffirmed the validity of a patent protecting its QuantiFeron technology. The court's decision upholds Qiagen's ( QGEN ) intellectual property rights involving the German part of a European patent, which protects its technology in detecting latent tuberculosis, the company said late Tuesday....
Copyright 2023-2026 - www.financetom.com All Rights Reserved